BEIJING: Could Chinese pharmaceutical companies help mass-produce certain drugs to strengthen the global fight against Covid-19 that is already in its third year, and thus show that their products can be game-changers?...
Such a question won’t be dismissed in a jiffy anymore, industry insiders say. Given the contagious Omicron variants, what might prove effective are mass-produced, low-cost small-molecule oral antiviral drugs that can be stored easily and accessed widely by outpatients, they sa
综合
星报-商业
2022-04-20 00:00:00.0